Lin BioScience, Inc. (TPEX:6696)
Taiwan · Delayed Price · Currency is TWD 145.50
+2.00 (1.39%)
Jul 17, 2025, 10:46 AM CST
Lin BioScience Market Cap
Lin BioScience has a market cap or net worth of 11.87 billion as of July 16, 2025. Its market cap has increased by 67.94% in one year.
Market Cap
11.87B
Enterprise Value
9.20B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
145.50
Market Cap Chart
Since October 8, 2018, Lin BioScience's market cap has increased from 2.92B to 11.87B, an increase of 307.09%. That is a compound annual growth rate of 23.02%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 188.45B |
| PharmaEssentia | 174.63B |
| Bora Pharmaceuticals Co., LTD. | 86.16B |
| Lotus Pharmaceutical | 55.75B |
| Polaris Group | 29.28B |
| Oneness Biotech | 29.27B |
| Center Laboratories | 26.92B |
| Lumosa Therapeutics | 23.63B |